Dec 01, 2020 05:40 JST

Source: China Shineway Pharmaceutical Group Limited

China Shineway Pharmaceutical records 29.4% revenue growth in October

HONG KONG, Dec 01, 2020 - (ACN Newswire) - China Shineway Pharmaceutical (stock code: 2877.HK) recorded 29.4% revenue growth for October 2020 in comparison with the same period last year, as sales of injection products, soft capsule products, granule products, TCM formula granules, and other dosage forms went up 38.9%, 17.4%, 38.1%, 7.9% and 54.0% respectively.

Source: China Shineway Pharmaceutical Group Limited
Sectors: Healthcare & Pharm

Copyright ©2024 ACN Newswire. All rights reserved. A division of Asia Corporate News Network.


Latest Release

More Latest Release >>